• Access To Medicines

Influencing and shaping our sector, BIA update: July - October 2018

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from July to October 2018.

BIA response to the Department of Health and Social Care's consultation on proposed changes to the statutory scheme to control costs of branded health service medicines

The BIA has responded to the Department of Health and Social Care's consultation on proposed changes to the statutory scheme to control costs of branded health service medicines.

BIA's response to the Department of Health and Social Care's consultation on NICE recommendations - charging and appeal panels

The BIA has responded to the Department of Health and Social Care's consultation on NICE recommendations

Influencing and shaping our sector, BIA update: April - July 2018

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from April to July 2018.